Skip to main content
Erschienen in: American Journal of Clinical Dermatology 4/2008

01.08.2008 | Review Article

Imported Tropical Infectious Ulcers in Travelers

verfasst von: Dr Jim E. Zeegelaar, William R. Faber

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 4/2008

Einloggen, um Zugang zu erhalten

Abstract

Skin ulcers are a commonly encountered problem at departments of tropical dermatology in the Western world. Furthermore, the general dermatologist is likely to be consulted more often for imported chronic skin ulcers because of the ever-increasing travel to and from tropical countries. The most common cause of chronic ulceration throughout the world is probably pyoderma. However, in some parts of the world, cutaneous leishmaniasis is one of the most prevalent causes. Mycobacterium ulcerans is an important cause of chronic ulcers in West Africa.
Bacterial infections include pyoderma, mycobacterial infections, diphtheria, and anthrax. Pyoderma is caused by Staphylococcus aureus and/or β-hemolytic streptococci group A. This condition is a common cause of ulcerative skin lesions in tropical countries and is often encountered as a secondary infection in travelers. The diagnosis is often made on clinical grounds. Antibacterial treatment for pyoderma should preferably be based on culture outcome. Floxacillin is generally active against S. aureus and β-hemolytic streptococci. Infection with Mycobacterium ulcerans, M. marinum, and M. tuberculosis may cause ulcers. Buruli ulcers, which are caused by M. ulcerans, are endemic in foci in West Africa and have been reported as an imported disease in the Western world. Treatment is generally surgical, although a combination of rifampin (rifampicin) and streptomycin may be effective in the early stage. M. marinum causes occasional ulcerating lesions in humans. Treatment regimens consist of combinations containing clarithromycin, rifampin, or ethambutol. Cutaneous tuberculosis is rare in travelers but may be encountered in immigrants from developing countries. Treatment is with multiple drug regimens consisting of isoniazid, ethambutol, pyrazinamide, and rifampin. Cutaneous diphtheria is still endemic in many tropical countries. Cutaneous diphtheria ulcers are nonspecific and erythromycin and penicillin are both effective antibacterials. Antitoxin should be administered intramuscularly in suspected cases. Anthrax is caused by spore-forming Bacillus anthracis. This infection is still endemic in many tropical countries. Eschar formation, which sloughs and leaves behind a shallow ulcer at the site of inoculation, characterizes cutaneous anthrax. Penicillin and doxycycline are effective antibacterials.
Cutaneous leishmaniasis is caused by different species belonging to the genus Leishmania. The disorder is one of the ten most frequent causes of skin diseases in travelers returning from (sub)tropical countries. The clinical picture is diverse, ranging from a painless papule or nodule to an ulcer with or without a scab. Treatment depends on the clinical manifestations and the species involved.
Sporotrichosis, chromo(blasto)mycosis, and mycetoma are the most common mycoses that may be accompanied by ulceration. Infections are restricted to certain regions and often result from direct penetration of the fungus into the skin. Anti-mycotic treatment depends on the microorganism involved.
The most common causes of infectious skin ulceration encountered in patients from tropical countries who present at a department of tropical dermatology are reviewed in this article.
Literatur
1.
Zurück zum Zitat Ryan ET, Wilson ME, Kain KC. Illness after international travel. N Engl J Med 2002; 347: 505–16PubMedCrossRef Ryan ET, Wilson ME, Kain KC. Illness after international travel. N Engl J Med 2002; 347: 505–16PubMedCrossRef
2.
3.
Zurück zum Zitat Wilson ME, Chen LH. Dermatologic infectious diseases in international travelers. Curr Infect Dis Rep 2004; 6: 54–62PubMedCrossRef Wilson ME, Chen LH. Dermatologic infectious diseases in international travelers. Curr Infect Dis Rep 2004; 6: 54–62PubMedCrossRef
4.
Zurück zum Zitat Lucchina LC, Wilson ME, Drake LA. Dermatology and the recently returned traveler: infectious diseases with dermatologic manifestations. Int J Dermatol 1997; 36: 167–81PubMedCrossRef Lucchina LC, Wilson ME, Drake LA. Dermatology and the recently returned traveler: infectious diseases with dermatologic manifestations. Int J Dermatol 1997; 36: 167–81PubMedCrossRef
5.
Zurück zum Zitat Freedman DO, Weld LH, Kozarsky PE,et al. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med 2006; 354: 119–30PubMedCrossRef Freedman DO, Weld LH, Kozarsky PE,et al. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med 2006; 354: 119–30PubMedCrossRef
6.
Zurück zum Zitat Zeegelaar JE, Steketee WH, van Thiel PP. Changing pattern of imported cutaneous leishmaniasis in the Netherlands. Clin Exp Dermatol 2005; 30: 1–5PubMedCrossRef Zeegelaar JE, Steketee WH, van Thiel PP. Changing pattern of imported cutaneous leishmaniasis in the Netherlands. Clin Exp Dermatol 2005; 30: 1–5PubMedCrossRef
7.
Zurück zum Zitat Lupi O, Madkan V, Tyring SK. Tropical dermatology: bacterial tropical diseases. J Am Acad Dermatol 2006; 54: 559–78PubMedCrossRef Lupi O, Madkan V, Tyring SK. Tropical dermatology: bacterial tropical diseases. J Am Acad Dermatol 2006; 54: 559–78PubMedCrossRef
8.
9.
10.
Zurück zum Zitat Maddox JS, Ware JC, Dillon Jr HC. The natural history of streptococcal skin infection: prevention with topical antibiotics. J Am Acad Dermatol 1985; 13: 207–12PubMedCrossRef Maddox JS, Ware JC, Dillon Jr HC. The natural history of streptococcal skin infection: prevention with topical antibiotics. J Am Acad Dermatol 1985; 13: 207–12PubMedCrossRef
11.
Zurück zum Zitat Greene SL, Su WP, Muller SA. Ecthyma gangrenosum: report of clinical, histopathologic, and bacteriologic aspects of eight cases. J Am Acad Dermatol 1984; 11: 781–7PubMedCrossRef Greene SL, Su WP, Muller SA. Ecthyma gangrenosum: report of clinical, histopathologic, and bacteriologic aspects of eight cases. J Am Acad Dermatol 1984; 11: 781–7PubMedCrossRef
12.
Zurück zum Zitat Dillon Jr HC. Post-streptococcal glomerulonephritis following pyoderma. Rev Infect Dis 1979; 1: 935–45PubMedCrossRef Dillon Jr HC. Post-streptococcal glomerulonephritis following pyoderma. Rev Infect Dis 1979; 1: 935–45PubMedCrossRef
13.
Zurück zum Zitat Alausa OK, Montefiore D. Bacterial infections, sensitivity patterns, and chemotherapy among hospital patients in the tropics. Scand J Infect Dis 1978; 10: 295–302PubMed Alausa OK, Montefiore D. Bacterial infections, sensitivity patterns, and chemotherapy among hospital patients in the tropics. Scand J Infect Dis 1978; 10: 295–302PubMed
14.
Zurück zum Zitat Rotta J, Tikhomirov E. Streptococcal diseases worldwide: present status and prospects. Bull World Health Organ 1987; 65: 769–77PubMed Rotta J, Tikhomirov E. Streptococcal diseases worldwide: present status and prospects. Bull World Health Organ 1987; 65: 769–77PubMed
15.
Zurück zum Zitat Mahe A, Prual A, Konate M,et al. Skin diseases of children in Mali: a public health problem. Trans R Soc Trop Med Hyg 1995; 89: 467–70PubMedCrossRef Mahe A, Prual A, Konate M,et al. Skin diseases of children in Mali: a public health problem. Trans R Soc Trop Med Hyg 1995; 89: 467–70PubMedCrossRef
16.
Zurück zum Zitat Brahmadathan KN, Koshi G. Epidemiology of streptococcal pyoderma in an orphanage community of a tropical country. J Trop Med Hyg 1988; 91: 306–14PubMed Brahmadathan KN, Koshi G. Epidemiology of streptococcal pyoderma in an orphanage community of a tropical country. J Trop Med Hyg 1988; 91: 306–14PubMed
17.
Zurück zum Zitat Caumes E, Carriere J, Guermonprez G,et al. Dermatoses associated with travel to tropical countries: a prospective study of the diagnosis and management of 269 patients presenting to a tropical disease unit. Clin Infect Dis 1995; 20: 542–8PubMedCrossRef Caumes E, Carriere J, Guermonprez G,et al. Dermatoses associated with travel to tropical countries: a prospective study of the diagnosis and management of 269 patients presenting to a tropical disease unit. Clin Infect Dis 1995; 20: 542–8PubMedCrossRef
18.
Zurück zum Zitat Naafs B. Tropical holiday memories. Eur J Dermatol 1999; 9: 500–5PubMed Naafs B. Tropical holiday memories. Eur J Dermatol 1999; 9: 500–5PubMed
19.
Zurück zum Zitat Brahmadathan KN, Koshi G. Importance of group G streptococci in human pyogenic infections. J Trop Med Hyg 1989; 92: 35–8PubMed Brahmadathan KN, Koshi G. Importance of group G streptococci in human pyogenic infections. J Trop Med Hyg 1989; 92: 35–8PubMed
21.
Zurück zum Zitat Allen AM, Taplin D, Twigg L. Cutaneous streptococcal infections in Vietnam. Arch Dermatol 1971; 104: 271–80PubMedCrossRef Allen AM, Taplin D, Twigg L. Cutaneous streptococcal infections in Vietnam. Arch Dermatol 1971; 104: 271–80PubMedCrossRef
22.
Zurück zum Zitat Sheagren JN. Staphylococcal infections of the skin and skin structures. Cutis 1985; 36: 2–6PubMed Sheagren JN. Staphylococcal infections of the skin and skin structures. Cutis 1985; 36: 2–6PubMed
23.
Zurück zum Zitat Bisno AL, Stevens DL. Streptococcal infections of skin and soft tissues. N Engl J Med 1996; 334: 240–5PubMedCrossRef Bisno AL, Stevens DL. Streptococcal infections of skin and soft tissues. N Engl J Med 1996; 334: 240–5PubMedCrossRef
25.
26.
Zurück zum Zitat Basak S, Dutta SK, Gupta S,et al. Bacteriology of wound infection: evaluation by surface swab and quantitative full thickness wound biopsy culture. J Indian Med Assoc 1992; 90: 33–4PubMed Basak S, Dutta SK, Gupta S,et al. Bacteriology of wound infection: evaluation by surface swab and quantitative full thickness wound biopsy culture. J Indian Med Assoc 1992; 90: 33–4PubMed
27.
Zurück zum Zitat Slater RA, Lazarovitch T, Boldur I,et al.Swab cultures accurately identify bacterial pathogens in diabetic foot wounds not involving bone. Diabet Med 2004; 21: 705–9PubMedCrossRef Slater RA, Lazarovitch T, Boldur I,et al.Swab cultures accurately identify bacterial pathogens in diabetic foot wounds not involving bone. Diabet Med 2004; 21: 705–9PubMedCrossRef
28.
Zurück zum Zitat Bill TJ, Ratliff CR, Donovan AM,et al. Quantitative swab culture versus tissue biopsy: a comparison in chronic wounds. Ostomy Wound Manage 2001; 47: 34–7PubMed Bill TJ, Ratliff CR, Donovan AM,et al. Quantitative swab culture versus tissue biopsy: a comparison in chronic wounds. Ostomy Wound Manage 2001; 47: 34–7PubMed
29.
Zurück zum Zitat Perry CR, Pearson RL, Miller GA. Accuracy of cultures of material from swabbing of the superficial aspect of the wound and needle biopsy in the preoperative assessment of osteomyelitis. J Bone Joint Surg Am 1991; 73: 745–9PubMed Perry CR, Pearson RL, Miller GA. Accuracy of cultures of material from swabbing of the superficial aspect of the wound and needle biopsy in the preoperative assessment of osteomyelitis. J Bone Joint Surg Am 1991; 73: 745–9PubMed
30.
Zurück zum Zitat Nagaraju U, Bhat G, Kuruvila M,et al. Methicillin-resistant Staphylococcus aureus in community acquired pyoderma. Int J Dermatol 2004; 43: 412–4PubMedCrossRef Nagaraju U, Bhat G, Kuruvila M,et al. Methicillin-resistant Staphylococcus aureus in community acquired pyoderma. Int J Dermatol 2004; 43: 412–4PubMedCrossRef
31.
Zurück zum Zitat Zeegelaar IE, Langenberg W, Hu R,et al. Tolerability and efficacy of hydrocolloid dressings in the treatment of venous leg ulcers under tropical conditions: an open prospective study. J Eur Acad Dermatol Venereol 2001; 15: 234–7PubMedCrossRef Zeegelaar IE, Langenberg W, Hu R,et al. Tolerability and efficacy of hydrocolloid dressings in the treatment of venous leg ulcers under tropical conditions: an open prospective study. J Eur Acad Dermatol Venereol 2001; 15: 234–7PubMedCrossRef
32.
Zurück zum Zitat Price JD, Harding JW. Flucloxacillin in the treatment of infectious conditions in children. Curr Med Res Opin 1975; 3: 77–82PubMedCrossRef Price JD, Harding JW. Flucloxacillin in the treatment of infectious conditions in children. Curr Med Res Opin 1975; 3: 77–82PubMedCrossRef
33.
Zurück zum Zitat Duncan JT. A clinical appraisal of flucloxacillin in the management of skin and soft tissue infections in Nigeria. J Int Med Res 1984; 12: 210–5PubMed Duncan JT. A clinical appraisal of flucloxacillin in the management of skin and soft tissue infections in Nigeria. J Int Med Res 1984; 12: 210–5PubMed
34.
Zurück zum Zitat Crofts HG. Flucloxacillin (Floxapen) in the treatment of skin and upper respiratory tract infections. N Z Med J 1978; 87: 308–11PubMed Crofts HG. Flucloxacillin (Floxapen) in the treatment of skin and upper respiratory tract infections. N Z Med J 1978; 87: 308–11PubMed
35.
Zurück zum Zitat Korting HC, Neubert U, Abeck D. Current antimicrobial susceptibility of cutaneous bacteria to firstline antibiotics. Int J Antimicrob Agents 1998; 10: 165–8PubMedCrossRef Korting HC, Neubert U, Abeck D. Current antimicrobial susceptibility of cutaneous bacteria to firstline antibiotics. Int J Antimicrob Agents 1998; 10: 165–8PubMedCrossRef
36.
Zurück zum Zitat Moellering JrRC. Past, present, and future of antimicrobial agents. Am J Med 1995; 99: 11–8SCrossRef Moellering JrRC. Past, present, and future of antimicrobial agents. Am J Med 1995; 99: 11–8SCrossRef
37.
Zurück zum Zitat Fung HB, Chang JY, Kuczynski S. A practical guide to the treatment of complicated skin and soft tissue infections. Drugs 2003; 63: 1459–80PubMedCrossRef Fung HB, Chang JY, Kuczynski S. A practical guide to the treatment of complicated skin and soft tissue infections. Drugs 2003; 63: 1459–80PubMedCrossRef
38.
Zurück zum Zitat Staphylococcus aureus resistant to vancomycin: United States, 2002. MMWR Morb Mortal Wkly Rep 2002; 51: 565–7 Staphylococcus aureus resistant to vancomycin: United States, 2002. MMWR Morb Mortal Wkly Rep 2002; 51: 565–7
39.
Zurück zum Zitat Winter GD, Scales JT. Effect of air drying and dressings on the surface of a wound. Nature 1963; 197: 91–2PubMedCrossRef Winter GD, Scales JT. Effect of air drying and dressings on the surface of a wound. Nature 1963; 197: 91–2PubMedCrossRef
40.
Zurück zum Zitat Hautmann G, Lotti T. Atypical mycobacterial infections of the skin. Dermatol Cli 1994; 12: 657–68 Hautmann G, Lotti T. Atypical mycobacterial infections of the skin. Dermatol Cli 1994; 12: 657–68
41.
Zurück zum Zitat Kostman JR, DiNubile MJ. Nodular lymphangitis: a distinctive but often unrecognized syndrome. Ann Intern Med 1993; 118: 883–8PubMed Kostman JR, DiNubile MJ. Nodular lymphangitis: a distinctive but often unrecognized syndrome. Ann Intern Med 1993; 118: 883–8PubMed
42.
Zurück zum Zitat van der Werf TS, van der Graaf WT, Tappero JW,. Mycobacterium ulcerans infection. Lancet 1999; 354: 1013–8PubMedCrossRef van der Werf TS, van der Graaf WT, Tappero JW,. Mycobacterium ulcerans infection. Lancet 1999; 354: 1013–8PubMedCrossRef
43.
Zurück zum Zitat Dodiuk-Gad R, Dyachenko P, Ziv M, et al. Nontuberculous mycobacterial infections of the skin: a retrospective study of 25 cases. J Am Acad Dermatol 2007; 57 (3): 413–20PubMedCrossRef Dodiuk-Gad R, Dyachenko P, Ziv M, et al. Nontuberculous mycobacterial infections of the skin: a retrospective study of 25 cases. J Am Acad Dermatol 2007; 57 (3): 413–20PubMedCrossRef
44.
45.
Zurück zum Zitat Wayne LG, Sramek HA. Agents of newly recognized or infrequently encountered mycobacterial diseases. Clin Microbiol Rev 1992; 5: 1–25PubMed Wayne LG, Sramek HA. Agents of newly recognized or infrequently encountered mycobacterial diseases. Clin Microbiol Rev 1992; 5: 1–25PubMed
46.
Zurück zum Zitat Street ML, Umbert-Millet IJ, Roberts GD,et al. Nontuberculous mycobacterial infections of the skin: report of fourteen cases and review of the literature. J Am Acad Dermatol 1991; 24: 208–15PubMedCrossRef Street ML, Umbert-Millet IJ, Roberts GD,et al. Nontuberculous mycobacterial infections of the skin: report of fourteen cases and review of the literature. J Am Acad Dermatol 1991; 24: 208–15PubMedCrossRef
47.
Zurück zum Zitat Clancey JK. Mycobacterial skin ulcers in Uganda: description of a new mycobacterium (Mycobacterium buruli). J Pathol Bacteriol 1964; 88: 175–87PubMedCrossRef Clancey JK. Mycobacterial skin ulcers in Uganda: description of a new mycobacterium (Mycobacterium buruli). J Pathol Bacteriol 1964; 88: 175–87PubMedCrossRef
48.
Zurück zum Zitat Portaels F, Chemlal K, Elsen P,et al. Mycobacterium ulcerans in wild animals. Rev Sci Tech 2001; 20: 252–64PubMed Portaels F, Chemlal K, Elsen P,et al. Mycobacterium ulcerans in wild animals. Rev Sci Tech 2001; 20: 252–64PubMed
49.
Zurück zum Zitat Eddyani M, Ofori-Adjei D, Teugels G,et al. Potential role for fish in transmission of Mycobacterium ulcerans disease (Buruli ulcer): an environmental study. Appl Environ Microbiol 2004; 70: 5679–81PubMedCrossRef Eddyani M, Ofori-Adjei D, Teugels G,et al. Potential role for fish in transmission of Mycobacterium ulcerans disease (Buruli ulcer): an environmental study. Appl Environ Microbiol 2004; 70: 5679–81PubMedCrossRef
50.
Zurück zum Zitat Portaels F, Elsen P, Guimaraes-Peres A, et al. Insects in the transmission of Mycobacterium ulcerans infection [letter]. Lancet 1999; 353: 986PubMedCrossRef Portaels F, Elsen P, Guimaraes-Peres A, et al. Insects in the transmission of Mycobacterium ulcerans infection [letter]. Lancet 1999; 353: 986PubMedCrossRef
51.
Zurück zum Zitat Marston BJ, Diallo MO, Horsburgh Jr CR, et al. Emergence of Buruli ulcer disease in the Daloa region of Cote d’Ivoire. Am J Trop Med Hyg 1995; 52: 219–24PubMed Marston BJ, Diallo MO, Horsburgh Jr CR, et al. Emergence of Buruli ulcer disease in the Daloa region of Cote d’Ivoire. Am J Trop Med Hyg 1995; 52: 219–24PubMed
52.
Zurück zum Zitat Debacker M, Aguiar J, Steunou C, et al. Buruli ulcer recurrence, Benin. Emerg Infect Dis 2005; 11: 584–9PubMedCrossRef Debacker M, Aguiar J, Steunou C, et al. Buruli ulcer recurrence, Benin. Emerg Infect Dis 2005; 11: 584–9PubMedCrossRef
53.
Zurück zum Zitat Amofah G, Bonsu F, Tetteh C, et al. Buruli ulcer in Ghana: results of a national case search. Emerg Infect Dis 2002; 8: 167–70PubMedCrossRef Amofah G, Bonsu F, Tetteh C, et al. Buruli ulcer in Ghana: results of a national case search. Emerg Infect Dis 2002; 8: 167–70PubMedCrossRef
54.
Zurück zum Zitat Barker DJ. Epidemiology of Mycobacterium ulcerans infection. Trans R Soc Trop Med Hyg 1973; 67: 43–50PubMedCrossRef Barker DJ. Epidemiology of Mycobacterium ulcerans infection. Trans R Soc Trop Med Hyg 1973; 67: 43–50PubMedCrossRef
55.
Zurück zum Zitat Semret M, Koromihis G, MacLean JD,et al. Mycobacterium ulcerans infection (Buruli ulcer): first reported case in a traveler. Am J Trop Med Hyg 1999; 61: 689–93PubMed Semret M, Koromihis G, MacLean JD,et al. Mycobacterium ulcerans infection (Buruli ulcer): first reported case in a traveler. Am J Trop Med Hyg 1999; 61: 689–93PubMed
56.
Zurück zum Zitat Faber WR, Arias-Bouda LM, Zeegelaar JE,et al. First reported case of Mycobacterium ulcerans infection in a patient from China. Trans R Soc Trop Med Hyg 2000; 94: 277–9PubMedCrossRef Faber WR, Arias-Bouda LM, Zeegelaar JE,et al. First reported case of Mycobacterium ulcerans infection in a patient from China. Trans R Soc Trop Med Hyg 2000; 94: 277–9PubMedCrossRef
57.
Zurück zum Zitat Evans MR, Mawdsley J, Bull R,et al. Buruli ulcer in a visitor to London. Br J Dermatol 2003; 149: 907–9PubMedCrossRef Evans MR, Mawdsley J, Bull R,et al. Buruli ulcer in a visitor to London. Br J Dermatol 2003; 149: 907–9PubMedCrossRef
58.
Zurück zum Zitat Ross BC, Johnson PD, Oppedisano F, et al. Detection of Mycobacterium ulcerans in environmental samples during an outbreak of ulcerative disease. Appl Environ Microbiol 1997; 63: 4135–8PubMed Ross BC, Johnson PD, Oppedisano F, et al. Detection of Mycobacterium ulcerans in environmental samples during an outbreak of ulcerative disease. Appl Environ Microbiol 1997; 63: 4135–8PubMed
59.
Zurück zum Zitat Portaels F, Meyers WM. Buruli ulcer. In: Faber WR, Hay RJ, Naafs B, editors. Imported skin diseases. Maarssen: Elsevier, 2006 Portaels F, Meyers WM. Buruli ulcer. In: Faber WR, Hay RJ, Naafs B, editors. Imported skin diseases. Maarssen: Elsevier, 2006
60.
Zurück zum Zitat Hayman J. Out of Africa: observations on the histopathology of Mycobacterium ulcerans infection. J Clin Pathol 1993; 46: 5–9PubMedCrossRef Hayman J. Out of Africa: observations on the histopathology of Mycobacterium ulcerans infection. J Clin Pathol 1993; 46: 5–9PubMedCrossRef
61.
Zurück zum Zitat Meyers WM, Shelly WM, Connor DH. Heat treatment of Mycobacterium ulcerans infections without surgical excision. Am J Trop Med Hyg 1974; 23: 924–9PubMed Meyers WM, Shelly WM, Connor DH. Heat treatment of Mycobacterium ulcerans infections without surgical excision. Am J Trop Med Hyg 1974; 23: 924–9PubMed
62.
Zurück zum Zitat Palomino JC, Obiang AM, Realini L,et al. Effect of oxygen on growth of Mycobacterium ulcerans in the BACTEC system. J Clin Microbiol 1998; 36: 3420–2PubMed Palomino JC, Obiang AM, Realini L,et al. Effect of oxygen on growth of Mycobacterium ulcerans in the BACTEC system. J Clin Microbiol 1998; 36: 3420–2PubMed
63.
Zurück zum Zitat Roberts B, Hirst R. Immunomagnetic separation and PCR for detection of Mycobacterium ulcerans. J Clin Microbiol 1997; 35: 2709–11PubMed Roberts B, Hirst R. Immunomagnetic separation and PCR for detection of Mycobacterium ulcerans. J Clin Microbiol 1997; 35: 2709–11PubMed
64.
Zurück zum Zitat Ross BC, Marino L, Oppedisano F, et al. Development of a PCR assay for rapid diagnosis of Mycobacterium ulcerans infection. J Clin Microbiol 1997; 35: 1696–700PubMed Ross BC, Marino L, Oppedisano F, et al. Development of a PCR assay for rapid diagnosis of Mycobacterium ulcerans infection. J Clin Microbiol 1997; 35: 1696–700PubMed
65.
Zurück zum Zitat Stienstra Y, van der Werf TS, Guarner J,et al. Analysis of an IS2404-based nested PCR for diagnosis of Buruli ulcer disease in regions of Ghana where the disease is endemic. J Clin Microbiol 2003; 41: 794–7PubMedCrossRef Stienstra Y, van der Werf TS, Guarner J,et al. Analysis of an IS2404-based nested PCR for diagnosis of Buruli ulcer disease in regions of Ghana where the disease is endemic. J Clin Microbiol 2003; 41: 794–7PubMedCrossRef
66.
Zurück zum Zitat Buruli ulcer disease. Wkly Epidemiol Rec 2004; 79: 194–9 Buruli ulcer disease. Wkly Epidemiol Rec 2004; 79: 194–9
67.
Zurück zum Zitat Dega H, Bentoucha A, Robert J,et al. Bactericidal activity of rifampin-amikacin against Mycobacterium ulcerans in mice. Antimicrob Agents Chemother 2002; 46: 3193–6PubMedCrossRef Dega H, Bentoucha A, Robert J,et al. Bactericidal activity of rifampin-amikacin against Mycobacterium ulcerans in mice. Antimicrob Agents Chemother 2002; 46: 3193–6PubMedCrossRef
69.
Zurück zum Zitat Lewis FM, Marsh BJ, von Reyn CF. Fish tank exposure and cutaneous infections due to Mycobacterium marinum: tuberculin skin testing, treatment, and prevention. Clin Infect Dis 2003; 37: 390–7PubMedCrossRef Lewis FM, Marsh BJ, von Reyn CF. Fish tank exposure and cutaneous infections due to Mycobacterium marinum: tuberculin skin testing, treatment, and prevention. Clin Infect Dis 2003; 37: 390–7PubMedCrossRef
70.
Zurück zum Zitat Chemlal K, Portaels F. Molecular diagnosis of nontuberculous mycobacteria. Curr Opin Infect Dis 2003; 16: 77–83PubMedCrossRef Chemlal K, Portaels F. Molecular diagnosis of nontuberculous mycobacteria. Curr Opin Infect Dis 2003; 16: 77–83PubMedCrossRef
71.
Zurück zum Zitat Bayer-Garner IB, Cox MD, Scott MA,et al. Mycobacteria other than Mycobacterium tuberculosis are not present in erythema induratum/nodular vasculitis: a case series and literature review of the clinical and histologic findings. J Cutan Pathol 2005; 32: 220–6PubMedCrossRef Bayer-Garner IB, Cox MD, Scott MA,et al. Mycobacteria other than Mycobacterium tuberculosis are not present in erythema induratum/nodular vasculitis: a case series and literature review of the clinical and histologic findings. J Cutan Pathol 2005; 32: 220–6PubMedCrossRef
72.
Zurück zum Zitat Braback M, Riesbeck K, Forsgren A. Susceptibilities of Mycobacterium marinum to gatifloxacin, gemifloxacin, levofloxacin, linezolid, moxifloxacin, telithromycin, and quinupristin-dalfopristin (Synercid) compared to its susceptibilities to reference macrolides and quinolones. Antimicrob Agents Chemother 2002; 46: 1114–6PubMedCrossRef Braback M, Riesbeck K, Forsgren A. Susceptibilities of Mycobacterium marinum to gatifloxacin, gemifloxacin, levofloxacin, linezolid, moxifloxacin, telithromycin, and quinupristin-dalfopristin (Synercid) compared to its susceptibilities to reference macrolides and quinolones. Antimicrob Agents Chemother 2002; 46: 1114–6PubMedCrossRef
73.
Zurück zum Zitat Gimenez GR, Sanchez RS, Iban Ochoa RM, et al. Fish tank granuloma: response to treatment with clarithromycin. J Eur Acad Dermatol Venereol 1999; 12: 81–2 Gimenez GR, Sanchez RS, Iban Ochoa RM, et al. Fish tank granuloma: response to treatment with clarithromycin. J Eur Acad Dermatol Venereol 1999; 12: 81–2
74.
Zurück zum Zitat Yates VM, Ormerod LP. Cutaneous tuberculosis in Blackburn district (U.K.): a 15-year prospective series, 1981-95. Br J Dermatol 1997; 136: 483–9PubMedCrossRef Yates VM, Ormerod LP. Cutaneous tuberculosis in Blackburn district (U.K.): a 15-year prospective series, 1981-95. Br J Dermatol 1997; 136: 483–9PubMedCrossRef
75.
Zurück zum Zitat Beutner EH. Tuberculosis of the skin: historical perspectives on tuberculin and Bacille Calmette Guerin. Int J Dermatol 1997; 36: 73–7PubMedCrossRef Beutner EH. Tuberculosis of the skin: historical perspectives on tuberculin and Bacille Calmette Guerin. Int J Dermatol 1997; 36: 73–7PubMedCrossRef
77.
Zurück zum Zitat Barbagallo J, Tager P, Ingleton R,et al. Cutaneous tuberculosis: diagnosis and treatment. Am J Clin Dermatol 2002; 3: 319–28PubMedCrossRef Barbagallo J, Tager P, Ingleton R,et al. Cutaneous tuberculosis: diagnosis and treatment. Am J Clin Dermatol 2002; 3: 319–28PubMedCrossRef
78.
Zurück zum Zitat Seckin D, Akpolat T, Ceyhan M,et al. Polymerase chain reaction in cutaneous tuberculosis. Int J Dermatol 1997; 36: 51–4PubMedCrossRef Seckin D, Akpolat T, Ceyhan M,et al. Polymerase chain reaction in cutaneous tuberculosis. Int J Dermatol 1997; 36: 51–4PubMedCrossRef
80.
Zurück zum Zitat Wagner J, Ignatius R, Voss S, et al. Infection of the skin caused by Corynebacterium ulcerans and mimicking classical cutaneous diphtheria. Clin Infect Dis 2001; 33: 1598–600PubMedCrossRef Wagner J, Ignatius R, Voss S, et al. Infection of the skin caused by Corynebacterium ulcerans and mimicking classical cutaneous diphtheria. Clin Infect Dis 2001; 33: 1598–600PubMedCrossRef
81.
82.
Zurück zum Zitat Koopman JS, Campbell J. The role of cutaneous diphtheria infections in a diphtheria epidemic. J Infect Dis 1975; 131: 239–44PubMedCrossRef Koopman JS, Campbell J. The role of cutaneous diphtheria infections in a diphtheria epidemic. J Infect Dis 1975; 131: 239–44PubMedCrossRef
83.
Zurück zum Zitat Kjeldsen K, Simonsen O, Heron I. Immunity against diphtheria 25-30 years after primary vaccination in childhood. Lancet 1985; I: 900–2CrossRef Kjeldsen K, Simonsen O, Heron I. Immunity against diphtheria 25-30 years after primary vaccination in childhood. Lancet 1985; I: 900–2CrossRef
84.
Zurück zum Zitat de Benoist AC, White JM, Efstratiou A,et al. Imported cutaneous diphtheria, United Kingdom. Emerg Infect Dis 2004; 10: 511–3PubMedCrossRef de Benoist AC, White JM, Efstratiou A,et al. Imported cutaneous diphtheria, United Kingdom. Emerg Infect Dis 2004; 10: 511–3PubMedCrossRef
85.
Zurück zum Zitat Van den Enden E, Van Gompel A, Van Esbroeck M. Cutaneous anthrax, Belgian traveler. Emerg Infect Dis 2006; 12: 523–5PubMedCrossRef Van den Enden E, Van Gompel A, Van Esbroeck M. Cutaneous anthrax, Belgian traveler. Emerg Infect Dis 2006; 12: 523–5PubMedCrossRef
86.
Zurück zum Zitat Swartz MN. Recognition and management of anthrax: an update. N Engl J Med 2001; 345: 1621–6PubMedCrossRef Swartz MN. Recognition and management of anthrax: an update. N Engl J Med 2001; 345: 1621–6PubMedCrossRef
87.
89.
Zurück zum Zitat Shlyakhov E, Rubinstein E. Evaluation of the anthraxin skin test for diagnosis of acute and past human anthrax. Eur J Clin Microbiol Infect Dis 1996; 15: 242–5PubMedCrossRef Shlyakhov E, Rubinstein E. Evaluation of the anthraxin skin test for diagnosis of acute and past human anthrax. Eur J Clin Microbiol Infect Dis 1996; 15: 242–5PubMedCrossRef
90.
Zurück zum Zitat Desjeux P. Leishmaniasis: public health aspects and control. Clin Dermatol 1996; 14: 417–23PubMedCrossRef Desjeux P. Leishmaniasis: public health aspects and control. Clin Dermatol 1996; 14: 417–23PubMedCrossRef
91.
Zurück zum Zitat Uzun S, Uslular C, Yucel A, et al. Cutaneous leishmaniasis: evaluation of 3,074 cases in the Cukurova region of Turkey. Br J Dermatol 1999; 140: 347–50PubMedCrossRef Uzun S, Uslular C, Yucel A, et al. Cutaneous leishmaniasis: evaluation of 3,074 cases in the Cukurova region of Turkey. Br J Dermatol 1999; 140: 347–50PubMedCrossRef
92.
Zurück zum Zitat Rowland M, Munir A, Durrani N,et al. An outbreak of cutaneous leishmaniasis in an Afghan refugee settlement in north-west Pakistan. Trans R Soc Trop Med Hyg 1999; 93: 133–6PubMedCrossRef Rowland M, Munir A, Durrani N,et al. An outbreak of cutaneous leishmaniasis in an Afghan refugee settlement in north-west Pakistan. Trans R Soc Trop Med Hyg 1999; 93: 133–6PubMedCrossRef
93.
Zurück zum Zitat Brooker S, Mohammed N, Adil K, et al. Leishmaniasis in refugee and local Pakistani populations. Emerg Infect Dis 2004; 10: 1681–4PubMedCrossRef Brooker S, Mohammed N, Adil K, et al. Leishmaniasis in refugee and local Pakistani populations. Emerg Infect Dis 2004; 10: 1681–4PubMedCrossRef
94.
Zurück zum Zitat Cupolillo E, Aguiar AF, Brahim LR, et al. Recent advances in the taxonomy of the New World leishmanial parasites. Med Microbiol Immunol (Berl) 2001; 190: 57–60 Cupolillo E, Aguiar AF, Brahim LR, et al. Recent advances in the taxonomy of the New World leishmanial parasites. Med Microbiol Immunol (Berl) 2001; 190: 57–60
95.
Zurück zum Zitat Cupolillo E, Brahim LR, Toaldo CB, et al. Genetic polymorphism and molecular epidemiology of Leishmania (Viannia) braziliensis from different hosts and geographic areas in Brazil. J Clin Microbiol 2003; 41: 3126–32PubMedCrossRef Cupolillo E, Brahim LR, Toaldo CB, et al. Genetic polymorphism and molecular epidemiology of Leishmania (Viannia) braziliensis from different hosts and geographic areas in Brazil. J Clin Microbiol 2003; 41: 3126–32PubMedCrossRef
96.
Zurück zum Zitat Marfurt J, Niederwieser I, Makia ND,et al. Diagnostic genotyping of Old and New World Leishmania species by PCR-RFLP. Diagn Microbiol Infect Dis 2003; 46: 115–24PubMedCrossRef Marfurt J, Niederwieser I, Makia ND,et al. Diagnostic genotyping of Old and New World Leishmania species by PCR-RFLP. Diagn Microbiol Infect Dis 2003; 46: 115–24PubMedCrossRef
97.
Zurück zum Zitat Cupolillo E, Momen H, Grimaldi Jr G. Genetic diversity in natural populations of New World Leishmania. Mem Inst Oswaldo Cruz 1998; 93: 663–8PubMedCrossRef Cupolillo E, Momen H, Grimaldi Jr G. Genetic diversity in natural populations of New World Leishmania. Mem Inst Oswaldo Cruz 1998; 93: 663–8PubMedCrossRef
98.
Zurück zum Zitat Lainson R, Shaw JJ. The laboratory mix-up of Leishmania strains [letter]. Trans R Soc Trop Med Hyg 1990; 84: 753PubMedCrossRef Lainson R, Shaw JJ. The laboratory mix-up of Leishmania strains [letter]. Trans R Soc Trop Med Hyg 1990; 84: 753PubMedCrossRef
99.
Zurück zum Zitat Shaw JJ. Taxonomy of the genus Leishmania: present and future trends and their implications. Mem Inst Oswaldo Cruz 1994; 89: 471–8PubMedCrossRef Shaw JJ. Taxonomy of the genus Leishmania: present and future trends and their implications. Mem Inst Oswaldo Cruz 1994; 89: 471–8PubMedCrossRef
100.
Zurück zum Zitat Rioux JA, Lanotte G, Serres E,et al. Taxonomy of Leishmania: use of isoenzymes. Suggestions for a new classification. Ann Parasitol Hum Comp 1990; 65: 111–25PubMed Rioux JA, Lanotte G, Serres E,et al. Taxonomy of Leishmania: use of isoenzymes. Suggestions for a new classification. Ann Parasitol Hum Comp 1990; 65: 111–25PubMed
101.
Zurück zum Zitat Killick-Kendrick R. Phlebotomine vectors of the leishmaniases: a review. Med Vet Entomol 1990; 4: 1–24PubMedCrossRef Killick-Kendrick R. Phlebotomine vectors of the leishmaniases: a review. Med Vet Entomol 1990; 4: 1–24PubMedCrossRef
102.
Zurück zum Zitat Killick-Kendrick R. The biology and control of phlebotomine sand flies. Clin Dermatol 1999; 17: 279–89PubMedCrossRef Killick-Kendrick R. The biology and control of phlebotomine sand flies. Clin Dermatol 1999; 17: 279–89PubMedCrossRef
103.
Zurück zum Zitat Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 2004; 27: 305–18PubMedCrossRef Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 2004; 27: 305–18PubMedCrossRef
104.
Zurück zum Zitat Bauer IL. Knowledge and behavior of tourists to Manu National Park, Peru, in relation to leishmaniasis. J Travel Med 2002; 9: 173–9PubMedCrossRef Bauer IL. Knowledge and behavior of tourists to Manu National Park, Peru, in relation to leishmaniasis. J Travel Med 2002; 9: 173–9PubMedCrossRef
105.
Zurück zum Zitat El Hajj L, Thellier M, Carriere J,et al. Localized cutaneous leishmaniasis imported into Paris: a review of 39 cases. Int J Dermatol 2004; 43: 120–5PubMedCrossRef El Hajj L, Thellier M, Carriere J,et al. Localized cutaneous leishmaniasis imported into Paris: a review of 39 cases. Int J Dermatol 2004; 43: 120–5PubMedCrossRef
106.
Zurück zum Zitat Harms G, Schonian G, Feldmeier H. Leishmaniasis in Germany. Emerg Infect Dis 2003; 9: 872–5PubMedCrossRef Harms G, Schonian G, Feldmeier H. Leishmaniasis in Germany. Emerg Infect Dis 2003; 9: 872–5PubMedCrossRef
107.
Zurück zum Zitat Schwartz E, Hatz C, Blum J. New World cutaneous leishmaniasis in travellers. Lancet Infect Dis 2006; 6: 342–9PubMedCrossRef Schwartz E, Hatz C, Blum J. New World cutaneous leishmaniasis in travellers. Lancet Infect Dis 2006; 6: 342–9PubMedCrossRef
108.
Zurück zum Zitat Guiguemde RT, Sawadogo OS, Bories C, et al. Leishmania major and HIV co-infection in Burkina Faso. Trans R Soc Trop Med Hyg 2003; 97: 168–9PubMedCrossRef Guiguemde RT, Sawadogo OS, Bories C, et al. Leishmania major and HIV co-infection in Burkina Faso. Trans R Soc Trop Med Hyg 2003; 97: 168–9PubMedCrossRef
109.
Zurück zum Zitat Maingon RD, Ward RD, Hamilton JG,et al. The Lutzomyia longipalpis species complex: does population sub-structure matter to leishmania transmission? Trends Parasitol 2008 Jan; 24 (1): 12–7PubMedCrossRef Maingon RD, Ward RD, Hamilton JG,et al. The Lutzomyia longipalpis species complex: does population sub-structure matter to leishmania transmission? Trends Parasitol 2008 Jan; 24 (1): 12–7PubMedCrossRef
110.
Zurück zum Zitat Uthman MA, Satir AA, Tabbara KS. Clinical and histopathological features of zoonotic cutaneous leishmaniasis in Saudi Arabia. J Eur Acad Dermatol Venereol 2005; 19: 431–6PubMedCrossRef Uthman MA, Satir AA, Tabbara KS. Clinical and histopathological features of zoonotic cutaneous leishmaniasis in Saudi Arabia. J Eur Acad Dermatol Venereol 2005; 19: 431–6PubMedCrossRef
111.
Zurück zum Zitat Jacobson RL, Eisenberger CL, Svobodova M,et al. Outbreak of cutaneous leish-maniasis in northern Israel. J Infect Dis 2003; 188: 1065–73PubMedCrossRef Jacobson RL, Eisenberger CL, Svobodova M,et al. Outbreak of cutaneous leish-maniasis in northern Israel. J Infect Dis 2003; 188: 1065–73PubMedCrossRef
112.
Zurück zum Zitat Al Tawfiq JA, AbuKhamsin A. Cutaneous leishmaniasis: a 46-year study of the epidemiology and clinical features in Saudi Arabia (1956-2002). Int J Infect Dis 2004; 8: 244–50CrossRef Al Tawfiq JA, AbuKhamsin A. Cutaneous leishmaniasis: a 46-year study of the epidemiology and clinical features in Saudi Arabia (1956-2002). Int J Infect Dis 2004; 8: 244–50CrossRef
113.
Zurück zum Zitat Sharma NL, Mahajan VK, Kanga A,et al. Localized cutaneous leishmaniasis due to Leishmania donovani and Leishmania tropica: preliminary findings of the study of 161 new cases from a new endemic focus in Himachal Pradesh, India. Am J Trop Med Hyg 2005; 72: 819–24PubMed Sharma NL, Mahajan VK, Kanga A,et al. Localized cutaneous leishmaniasis due to Leishmania donovani and Leishmania tropica: preliminary findings of the study of 161 new cases from a new endemic focus in Himachal Pradesh, India. Am J Trop Med Hyg 2005; 72: 819–24PubMed
114.
Zurück zum Zitat Barnetson RS, Ridley RS, Wheate HW. A form of muco-cutaneous leishmaniasis in the Old World. Trans R Soc Trop Med Hyg 1978; 72: 516–8PubMedCrossRef Barnetson RS, Ridley RS, Wheate HW. A form of muco-cutaneous leishmaniasis in the Old World. Trans R Soc Trop Med Hyg 1978; 72: 516–8PubMedCrossRef
115.
Zurück zum Zitat Morsy TA, Khalil NM, Salama MM,et al. Mucosal leishmaniasis caused by Leishmania tropica in Saudi Arabia. J Egypt Soc Parasitol 1995; 25: 73–9PubMed Morsy TA, Khalil NM, Salama MM,et al. Mucosal leishmaniasis caused by Leishmania tropica in Saudi Arabia. J Egypt Soc Parasitol 1995; 25: 73–9PubMed
116.
Zurück zum Zitat Oliveira CC, Lacerda HG, Martins DR,et al. Changing epidemiology of American cutaneous leishmaniasis (ACL) in Brazil: a disease of the urban-rural interface. Acta Trop 2004; 90: 155–62PubMedCrossRef Oliveira CC, Lacerda HG, Martins DR,et al. Changing epidemiology of American cutaneous leishmaniasis (ACL) in Brazil: a disease of the urban-rural interface. Acta Trop 2004; 90: 155–62PubMedCrossRef
117.
Zurück zum Zitat Romero GA, Ishikawa E, Cupolillo E,et al. The rarity of infection with Leishmania (Viannia) braziliensis among patients from the Manaus region of Amazonas state, Brazil, who have cutaneous leishmaniasis. Ann Trop Med Parasitol 2002; 96: 131–6PubMedCrossRef Romero GA, Ishikawa E, Cupolillo E,et al. The rarity of infection with Leishmania (Viannia) braziliensis among patients from the Manaus region of Amazonas state, Brazil, who have cutaneous leishmaniasis. Ann Trop Med Parasitol 2002; 96: 131–6PubMedCrossRef
118.
Zurück zum Zitat Corredor A, Kreutzer RD, Tesh RB,et al. Distribution and etiology of leishmaniasis in Colombia. Am J Trop Med Hyg 1990; 42: 206–14PubMed Corredor A, Kreutzer RD, Tesh RB,et al. Distribution and etiology of leishmaniasis in Colombia. Am J Trop Med Hyg 1990; 42: 206–14PubMed
119.
Zurück zum Zitat Velez I, Agudelo S, Robledo S,et al. Diffuse cutaneous leishmaniasis with mucosal involvement in Colombia, caused by an enzymatic variant of Leishmania panamensis. Trans R Soc Trop Med Hyg 1994; 88: 199PubMedCrossRef Velez I, Agudelo S, Robledo S,et al. Diffuse cutaneous leishmaniasis with mucosal involvement in Colombia, caused by an enzymatic variant of Leishmania panamensis. Trans R Soc Trop Med Hyg 1994; 88: 199PubMedCrossRef
120.
Zurück zum Zitat Turetz ML, Machado PR, Ko AI,et al. Disseminated leishmaniasis: a new and emerging form of leishmaniasis observed in northeastern Brazil. J Infect Dis 2002; 186: 1829–34PubMedCrossRef Turetz ML, Machado PR, Ko AI,et al. Disseminated leishmaniasis: a new and emerging form of leishmaniasis observed in northeastern Brazil. J Infect Dis 2002; 186: 1829–34PubMedCrossRef
121.
Zurück zum Zitat Silveira FT, Lainson R, Corbett CE. Clinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in Amazonian Brazil: a review. Mem Inst Oswaldo Cruz 2004; 99: 239–51PubMedCrossRef Silveira FT, Lainson R, Corbett CE. Clinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in Amazonian Brazil: a review. Mem Inst Oswaldo Cruz 2004; 99: 239–51PubMedCrossRef
122.
Zurück zum Zitat Silveira FT, Lainson R, Corbett CE. Further observations on clinical, histopathological, and immunological features of borderline disseminated cutaneous leishmaniasis caused by Leishmania (Leishmania) amazonensis. Mem Inst Oswaldo Cruz 2005; 100: 525–34PubMedCrossRef Silveira FT, Lainson R, Corbett CE. Further observations on clinical, histopathological, and immunological features of borderline disseminated cutaneous leishmaniasis caused by Leishmania (Leishmania) amazonensis. Mem Inst Oswaldo Cruz 2005; 100: 525–34PubMedCrossRef
123.
Zurück zum Zitat Reithinger R, Aadil K, Hami S,et al. Cutaneous leishmaniasis, northern Afghanistan. Emerg Infect Dis 2004; 10: 966–7PubMedCrossRef Reithinger R, Aadil K, Hami S,et al. Cutaneous leishmaniasis, northern Afghanistan. Emerg Infect Dis 2004; 10: 966–7PubMedCrossRef
124.
Zurück zum Zitat Magill AJ. Epidemiology of the leishmaniases. Dermatol Clin 1995; 13: 505–23PubMed Magill AJ. Epidemiology of the leishmaniases. Dermatol Clin 1995; 13: 505–23PubMed
125.
Zurück zum Zitat Navin TR, Arana FE, de Merida AM,et al. Cutaneous leishmaniasis in Guatemala: comparison of diagnostic methods. Am J Trop Med Hyg 1990; 42: 36–42PubMed Navin TR, Arana FE, de Merida AM,et al. Cutaneous leishmaniasis in Guatemala: comparison of diagnostic methods. Am J Trop Med Hyg 1990; 42: 36–42PubMed
126.
Zurück zum Zitat De Bruijn MH, Barker DC. Diagnosis of New World leishmaniasis: specific detection of species of the Leishmania braziliensis complex by amplification of kinetoplast DNA. Acta Trop 1992; 52: 45–58PubMedCrossRef De Bruijn MH, Barker DC. Diagnosis of New World leishmaniasis: specific detection of species of the Leishmania braziliensis complex by amplification of kinetoplast DNA. Acta Trop 1992; 52: 45–58PubMedCrossRef
127.
Zurück zum Zitat Weigle KA, de Davalos M, Heredia P,et al. Diagnosis of cutaneous and mucocutaneous leishmaniasis in Colombia: a comparison of seven methods. Am J Trop Med Hyg 1987; 36: 489–96PubMed Weigle KA, de Davalos M, Heredia P,et al. Diagnosis of cutaneous and mucocutaneous leishmaniasis in Colombia: a comparison of seven methods. Am J Trop Med Hyg 1987; 36: 489–96PubMed
128.
Zurück zum Zitat Kalter DC. Laboratory tests for the diagnosis and evaluation of leishmaniasis. Dermatol Clin 1994; 12: 37–50PubMed Kalter DC. Laboratory tests for the diagnosis and evaluation of leishmaniasis. Dermatol Clin 1994; 12: 37–50PubMed
129.
Zurück zum Zitat Faber WR, Oskam L, van Gool T,et al. Value of diagnostic techniques for cutaneous leishmaniasis. J Am Acad Dermatol 2003; 49: 70–4PubMedCrossRef Faber WR, Oskam L, van Gool T,et al. Value of diagnostic techniques for cutaneous leishmaniasis. J Am Acad Dermatol 2003; 49: 70–4PubMedCrossRef
130.
Zurück zum Zitat Sarantopoulos GP, Binder S, Wortmann G,et al. Old World cutaneous leishmaniasis in Los Angeles: a case report, overview of the current literature, and guide for the treating dermatopathologist. Am J Dermatopathol 2003; 25: 321–6PubMedCrossRef Sarantopoulos GP, Binder S, Wortmann G,et al. Old World cutaneous leishmaniasis in Los Angeles: a case report, overview of the current literature, and guide for the treating dermatopathologist. Am J Dermatopathol 2003; 25: 321–6PubMedCrossRef
131.
Zurück zum Zitat Herwaldt BL, Berman JD. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg 1992; 46: 296–306PubMed Herwaldt BL, Berman JD. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg 1992; 46: 296–306PubMed
132.
Zurück zum Zitat World Health Organization. The leishmaniases. WHO technical report series. Vol 701. Geneva: WHO, 1984 World Health Organization. The leishmaniases. WHO technical report series. Vol 701. Geneva: WHO, 1984
133.
Zurück zum Zitat Romero GA, Guerra MV, Paes MG,et al. Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate. Am J Trop Med Hyg 2001; 65: 456–65PubMed Romero GA, Guerra MV, Paes MG,et al. Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate. Am J Trop Med Hyg 2001; 65: 456–65PubMed
134.
Zurück zum Zitat Oliveira-Neto MP, Schubach A, Mattos M,et al. Treatment of American cutaneous leishmaniasis: a comparison between low dosage (5 mg/kg/day) and high dosage (20 mg/kg/day) antimony regimens. Pathol Biol (Paris) 1997; 45: 496–9 Oliveira-Neto MP, Schubach A, Mattos M,et al. Treatment of American cutaneous leishmaniasis: a comparison between low dosage (5 mg/kg/day) and high dosage (20 mg/kg/day) antimony regimens. Pathol Biol (Paris) 1997; 45: 496–9
135.
Zurück zum Zitat Oliveira-Neto MP, Schubach A, Mattos M,et al. Intralesional therapy of American cutaneous leishmaniasis with pentavalent antimony in Rio de Janeiro, Brazil: an area of Leishmania (V.) braziliensis transmission. Int J Dermatol 1997; 36: 463–8PubMedCrossRef Oliveira-Neto MP, Schubach A, Mattos M,et al. Intralesional therapy of American cutaneous leishmaniasis with pentavalent antimony in Rio de Janeiro, Brazil: an area of Leishmania (V.) braziliensis transmission. Int J Dermatol 1997; 36: 463–8PubMedCrossRef
136.
Zurück zum Zitat Blum J, Desjeux P, Schwartz E,et al. Treatment of cutaneous leishmaniasis among travellers. J Antimicrob Chemother 2004; 53: 158–66PubMedCrossRef Blum J, Desjeux P, Schwartz E,et al. Treatment of cutaneous leishmaniasis among travellers. J Antimicrob Chemother 2004; 53: 158–66PubMedCrossRef
137.
Zurück zum Zitat Lai A Fat EJ, Vrede MA, Soetosenojo RM,et al. Pentamidine, the drug of choice for the treatment of cutaneous leishmaniasis in Surinam. Int J Dermatol 2002; 41: 796–800CrossRef Lai A Fat EJ, Vrede MA, Soetosenojo RM,et al. Pentamidine, the drug of choice for the treatment of cutaneous leishmaniasis in Surinam. Int J Dermatol 2002; 41: 796–800CrossRef
138.
Zurück zum Zitat Tuon FF, Amato VS, Graf ME,et al. Treatment of New World cutaneous leishmaniasis: a systematic review with a meta-analysis. Int J Dermatol 2008 Feb; 47 (2): 109–24PubMedCrossRef Tuon FF, Amato VS, Graf ME,et al. Treatment of New World cutaneous leishmaniasis: a systematic review with a meta-analysis. Int J Dermatol 2008 Feb; 47 (2): 109–24PubMedCrossRef
139.
Zurück zum Zitat Soto J, Rea J, Balderrama M,et al. Efficacy of miltefosine for Bolivian cutaneous leishmaniasis. Am J Trop Med Hyg 2008 Feb; 78 (2): 210–1PubMed Soto J, Rea J, Balderrama M,et al. Efficacy of miltefosine for Bolivian cutaneous leishmaniasis. Am J Trop Med Hyg 2008 Feb; 78 (2): 210–1PubMed
140.
141.
Zurück zum Zitat Soto J, Soto P. Miltefosine: oral treatment of leishmaniasis. Expert Rev Anti Infect Ther 2006; 4: 177–85PubMedCrossRef Soto J, Soto P. Miltefosine: oral treatment of leishmaniasis. Expert Rev Anti Infect Ther 2006; 4: 177–85PubMedCrossRef
142.
Zurück zum Zitat Soto J, Toledo J, Valda L,et al. Treatment of Bolivian mucosal leishmaniasis with miltefosine. Clin Infect Dis 2007; 44: 350–6PubMedCrossRef Soto J, Toledo J, Valda L,et al. Treatment of Bolivian mucosal leishmaniasis with miltefosine. Clin Infect Dis 2007; 44: 350–6PubMedCrossRef
143.
Zurück zum Zitat El Safi SH, Murphy AG, Bryceson AD,et al. A double-blind clinical trial of the treatment of cutaneous leishmaniasis with paromomycin ointment. Trans R Soc Trop Med Hyg 1990; 84: 690–1PubMedCrossRef El Safi SH, Murphy AG, Bryceson AD,et al. A double-blind clinical trial of the treatment of cutaneous leishmaniasis with paromomycin ointment. Trans R Soc Trop Med Hyg 1990; 84: 690–1PubMedCrossRef
144.
Zurück zum Zitat El On J, Halevy S, Grunwald MH,et al. Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study. J Am Acad Dermatol 1992; 27: 227–31PubMedCrossRef El On J, Halevy S, Grunwald MH,et al. Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study. J Am Acad Dermatol 1992; 27: 227–31PubMedCrossRef
145.
Zurück zum Zitat Gurei MS, Tatli N, Ozbilge H,et al. Efficacy of cryotherapy and intralesional Pentostam in treatment of cutaneous leishmaniasis. J Egypt Soc Parasitol 2000; 30: 169–76PubMed Gurei MS, Tatli N, Ozbilge H,et al. Efficacy of cryotherapy and intralesional Pentostam in treatment of cutaneous leishmaniasis. J Egypt Soc Parasitol 2000; 30: 169–76PubMed
146.
Zurück zum Zitat Faris RM, Jarallah JS, Khoja TA,et al. Intralesional treatment of cutaneous leishmaniasis with sodium stibogluconate antimony. Int J Dermatol 1993; 32: 610–2PubMedCrossRef Faris RM, Jarallah JS, Khoja TA,et al. Intralesional treatment of cutaneous leishmaniasis with sodium stibogluconate antimony. Int J Dermatol 1993; 32: 610–2PubMedCrossRef
147.
Zurück zum Zitat Asilian A, Sadeghinia A, Faghihi G,et al. Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis. Int J Dermatol 2004; 43: 281–3PubMedCrossRef Asilian A, Sadeghinia A, Faghihi G,et al. Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis. Int J Dermatol 2004; 43: 281–3PubMedCrossRef
148.
Zurück zum Zitat Alrajhi AA, Ibrahim EA, De Vol EB,et al. Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. N Engl J Med 2002; 346: 891–5PubMedCrossRef Alrajhi AA, Ibrahim EA, De Vol EB,et al. Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. N Engl J Med 2002; 346: 891–5PubMedCrossRef
149.
Zurück zum Zitat Weinrauch L, Livshin R, El On J. Ketoconazole in cutaneous leishmaniasis. Br J Dermatol 1987; 117: 666–8PubMedCrossRef Weinrauch L, Livshin R, El On J. Ketoconazole in cutaneous leishmaniasis. Br J Dermatol 1987; 117: 666–8PubMedCrossRef
150.
Zurück zum Zitat Minodier P, Parola P. Cutaneous leishmaniasis treatment. Travel Med Infect Dis 2007 May; 5 (3): 150–8PubMedCrossRef Minodier P, Parola P. Cutaneous leishmaniasis treatment. Travel Med Infect Dis 2007 May; 5 (3): 150–8PubMedCrossRef
151.
Zurück zum Zitat Reithinger R, Mohsen M, Wahid M,et al. Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial. Clin Infect Dis 2005; 40: 1148–55PubMedCrossRef Reithinger R, Mohsen M, Wahid M,et al. Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial. Clin Infect Dis 2005; 40: 1148–55PubMedCrossRef
152.
153.
Zurück zum Zitat Barros MB, Schubach AO, do Valle AC, et al. Cat-transmitted sporotrichosis epidemic in Rio de Janeiro, Brazil: description of a series of cases. Clin Infect Dis 2004; 38: 529–35PubMedCrossRef Barros MB, Schubach AO, do Valle AC, et al. Cat-transmitted sporotrichosis epidemic in Rio de Janeiro, Brazil: description of a series of cases. Clin Infect Dis 2004; 38: 529–35PubMedCrossRef
154.
Zurück zum Zitat Schubach A, Schubach TM, Barros MB, et al. Cat-transmitted sporotrichosis, Rio de Janeiro, Brazil. SEmerg Infect Dis 2005; 11: 1952–4CrossRef Schubach A, Schubach TM, Barros MB, et al. Cat-transmitted sporotrichosis, Rio de Janeiro, Brazil. SEmerg Infect Dis 2005; 11: 1952–4CrossRef
155.
Zurück zum Zitat da Rosa AC, Scroferneker ML, Vettorato R, et al. Epidemiology of sporotrichosis: a study of 304 cases in Brazil. J Am Acad Dermatol 2005; 52: 451–9PubMedCrossRef da Rosa AC, Scroferneker ML, Vettorato R, et al. Epidemiology of sporotrichosis: a study of 304 cases in Brazil. J Am Acad Dermatol 2005; 52: 451–9PubMedCrossRef
156.
Zurück zum Zitat Neyra E, Fonteyne PA, Swinne D, et al. Epidemiology of human sporotrichosis investigated by amplified fragment length polymorphism. J Clin Microbiol 2005; 43: 1348–52PubMedCrossRef Neyra E, Fonteyne PA, Swinne D, et al. Epidemiology of human sporotrichosis investigated by amplified fragment length polymorphism. J Clin Microbiol 2005; 43: 1348–52PubMedCrossRef
157.
158.
Zurück zum Zitat Quintal D. Sporotrichosis infection on mines of the Witwatersrand. J Cutan Med Surg 2000; 4: 51–4PubMed Quintal D. Sporotrichosis infection on mines of the Witwatersrand. J Cutan Med Surg 2000; 4: 51–4PubMed
159.
160.
Zurück zum Zitat Carvalho MT, de Castro AP, Baby C, et al. Disseminated cutaneous sporotrichosis in a patient with AIDS: report of a case. Rev Soc Bras Med Trop 2002; 35: 655–9PubMedCrossRef Carvalho MT, de Castro AP, Baby C, et al. Disseminated cutaneous sporotrichosis in a patient with AIDS: report of a case. Rev Soc Bras Med Trop 2002; 35: 655–9PubMedCrossRef
161.
162.
Zurück zum Zitat Winn RE, Anderson J, Piper J, et al. Systemic sporotrichosis treated with itraconazole. Clin Infect Dis 1993; 17: 210–7PubMedCrossRef Winn RE, Anderson J, Piper J, et al. Systemic sporotrichosis treated with itraconazole. Clin Infect Dis 1993; 17: 210–7PubMedCrossRef
163.
Zurück zum Zitat Conti Diaz IA, Civila E, Gezuele E, et al. Treatment of human cutaneous sporotrichosis with itraconazole. Mycoses 1992; 35: 153–6 Conti Diaz IA, Civila E, Gezuele E, et al. Treatment of human cutaneous sporotrichosis with itraconazole. Mycoses 1992; 35: 153–6
164.
Zurück zum Zitat Chapman SW, Pappas P, Kauffmann C, et al. Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg day(-1)) in the treatment of cutaneous or lymphocutaneous sporotrichosis. Mycoses 2004; 47: 62–8PubMedCrossRef Chapman SW, Pappas P, Kauffmann C, et al. Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg day(-1)) in the treatment of cutaneous or lymphocutaneous sporotrichosis. Mycoses 2004; 47: 62–8PubMedCrossRef
165.
Zurück zum Zitat Cabezas C, Bustamante B, Holgado W, et al. Treatment of cutaneous sporotrichosis with one daily dose of potassium iodide. Pediatr Infect Dis J 1996; 15: 352–4PubMedCrossRef Cabezas C, Bustamante B, Holgado W, et al. Treatment of cutaneous sporotrichosis with one daily dose of potassium iodide. Pediatr Infect Dis J 1996; 15: 352–4PubMedCrossRef
166.
167.
Zurück zum Zitat Bonifaz A, Carrasco-Gerard E, Saul A. Chromoblastomycosis: clinical and mycologic experience of 51 cases. Mycoses 2001; 44: 1–7PubMedCrossRef Bonifaz A, Carrasco-Gerard E, Saul A. Chromoblastomycosis: clinical and mycologic experience of 51 cases. Mycoses 2001; 44: 1–7PubMedCrossRef
168.
Zurück zum Zitat Lupi O, Tyring SK, McGinnis MR. Tropical dermatology: fungal tropical diseases. J Am Acad DermatolS 2005; 53: 931–51, quizPubMedCrossRef Lupi O, Tyring SK, McGinnis MR. Tropical dermatology: fungal tropical diseases. J Am Acad DermatolS 2005; 53: 931–51, quizPubMedCrossRef
169.
Zurück zum Zitat Rivitti EA, Aoki V. Deep fungal infections in tropical countries. SClin Dermatol 1999; 17: 171–90CrossRef Rivitti EA, Aoki V. Deep fungal infections in tropical countries. SClin Dermatol 1999; 17: 171–90CrossRef
170.
Zurück zum Zitat Howles JK, Kennedy CB, Garvin WH, et al. Chromoblastomycosis: report of nine cases from a single area in Louisiana. AMA Arch Derm Syphilol 1954; 69: 83–90PubMedCrossRef Howles JK, Kennedy CB, Garvin WH, et al. Chromoblastomycosis: report of nine cases from a single area in Louisiana. AMA Arch Derm Syphilol 1954; 69: 83–90PubMedCrossRef
171.
Zurück zum Zitat Bonifaz A, Paredes-Solis V, Saul A. Treating chromoblastomycosis with systemic antifungals. SExpert Opin Pharmacother 2004; 5: 247–54CrossRef Bonifaz A, Paredes-Solis V, Saul A. Treating chromoblastomycosis with systemic antifungals. SExpert Opin Pharmacother 2004; 5: 247–54CrossRef
172.
Zurück zum Zitat Magana M, Magana-Garcia M. Mycetoma. Dermatol Clin 1989; 7: 203–17PubMed Magana M, Magana-Garcia M. Mycetoma. Dermatol Clin 1989; 7: 203–17PubMed
174.
175.
176.
Zurück zum Zitat Fahal AH, Sharfi AR, Sheik HE, et al. Internal fistula formation: an unusual complication of mycetoma. Trans R Soc Trop Med Hyg 1996; 90: 550–2PubMedCrossRef Fahal AH, Sharfi AR, Sheik HE, et al. Internal fistula formation: an unusual complication of mycetoma. Trans R Soc Trop Med Hyg 1996; 90: 550–2PubMedCrossRef
178.
Zurück zum Zitat Welsh O, Salinas MC, Rodriguez MA. Treatment of eumycetoma and actino- mycetoma. Curr Top Med Mycol 1995; 6: 47–71PubMed Welsh O, Salinas MC, Rodriguez MA. Treatment of eumycetoma and actino- mycetoma. Curr Top Med Mycol 1995; 6: 47–71PubMed
179.
180.
Zurück zum Zitat Bonifaz A, Flores P, Saul A, et al. Treatment of actinomycetoma due to Nocardia spp. with amoxicillin-clavulanate. Br J Dermatol 2007; 156: 308–11PubMedCrossRef Bonifaz A, Flores P, Saul A, et al. Treatment of actinomycetoma due to Nocardia spp. with amoxicillin-clavulanate. Br J Dermatol 2007; 156: 308–11PubMedCrossRef
Metadaten
Titel
Imported Tropical Infectious Ulcers in Travelers
verfasst von
Dr Jim E. Zeegelaar
William R. Faber
Publikationsdatum
01.08.2008
Verlag
Springer International Publishing
Erschienen in
American Journal of Clinical Dermatology / Ausgabe 4/2008
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI
https://doi.org/10.2165/00128071-200809040-00002

Weitere Artikel der Ausgabe 4/2008

American Journal of Clinical Dermatology 4/2008 Zur Ausgabe

Images in Dermatopathology

A Hairy Problem

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Studienlage spricht für Isotretinoin zur Rosazea-Therapie

23.05.2024 Rosazea Nachrichten

Isotretinoin wird off-label zur Behandlung von Rosazea eingesetzt. Wie solide die Evidenz dafür ist, wurde jetzt in einem systematischen Review überprüft.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Riesenzellarteriitis: 15% der Patienten sind von okkulter Form betroffen

16.05.2024 Riesenzellarteriitis Nachrichten

In einer retrospektiven Untersuchung haben Forschende aus Belgien und den Niederlanden die okkulte Form der Riesenzellarteriitis genauer unter die Lupe genommen. In puncto Therapie und Rezidivraten stellten sie keinen sehr großen Unterschied zu Erkrankten mit kranialen Symptomen fest.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.